These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37541747)

  • 1. Rationale for the shielding policy for clinically vulnerable people in the UK during the COVID-19 pandemic: a qualitative study.
    Porter A; Akbari A; Carson-Stevens A; Dale J; Dixon L; Edwards A; Evans B; Griffiths L; John A; Jolles S; Kingston MR; Lyons R; Morgan J; Sewell B; Whiffen A; Williams VA; Snooks H
    BMJ Open; 2023 Aug; 13(8):e073464. PubMed ID: 37541747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the shielding initiative in Wales (EVITE Immunity): protocol for a quasiexperimental study.
    Evans BA; Akbari A; Bailey R; Bethell L; Bufton S; Carson-Stevens A; Dixon L; Edwards A; John A; Jolles S; Kingston MR; Lyons J; Lyons R; Porter A; Sewell B; Thornton CA; Watkins A; Whiffen T; Snooks H
    BMJ Open; 2022 Sep; 12(9):e059813. PubMed ID: 36691218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost of implementing the COVID-19 shielding policy in Wales.
    Sewell B; Farr A; Akbari A; Carson-Stevens A; Dale J; Edwards A; Evans BA; John A; Torabi F; Jolles S; Kingston M; Lyons J; Lyons RA; Porter A; Watkins A; Williams V; Snooks H
    BMC Public Health; 2023 Nov; 23(1):2342. PubMed ID: 38008730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the impact of shielding advice on the wellbeing of individuals identified as clinically extremely vulnerable amid the COVID-19 pandemic: a mixed-methods evaluation.
    Lasseter G; Compston P; Robin C; Lambert H; Hickman M; Denford S; Reynolds R; Zhang J; Cai S; Zhang T; Smith LE; Rubin GJ; Yardley L; Amlôt R; Oliver I
    BMC Public Health; 2022 Nov; 22(1):2145. PubMed ID: 36418978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Did the UK's public health shielding policy protect the clinically extremely vulnerable during the COVID-19 pandemic in Wales? Results of EVITE Immunity, a linked data retrospective study.
    Snooks H; Watkins A; Lyons J; Akbari A; Bailey R; Bethell L; Carson-Stevens A; Edwards A; Emery H; Evans BA; Jolles S; John A; Kingston M; Porter A; Sewell B; Williams V; Lyons RA
    Public Health; 2023 May; 218():12-20. PubMed ID: 36933354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qualitative interview study of rheumatology patients' experiences of COVID-19 shielding to explore the physical and psychological impact and identify associated support needs.
    Silverthorne CA; Jones B; Brooke M; Coates LC; Orme J; Robson JC; Tillett W; Dures E
    BMJ Open; 2024 Apr; 14(4):e075871. PubMed ID: 38653512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of the national testing response during the COVID-19 pandemic in England: a multistage mixed-methods study protocol.
    Naidoo R; Lambert B; Voysey M; Shretta R; Keene CM; Wanat M; Andersen-Waine B; Dahal P; Stepniewska K; Hounsell R; Molyneux S; Pinto-Duschinsky S; Rowe E; Yenidogan G; Fowler T; White L; Consortium EHA
    BMJ Open; 2024 Jun; 14(6):e077271. PubMed ID: 38885988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects on mortality of shielding clinically extremely vulnerable patients in Liverpool, UK, during the COVID-19 pandemic.
    Filipe L; Barnett LA; Piroddi R; Buchan I; Duckworth H; Barr B
    Public Health; 2023 Sep; 222():54-59. PubMed ID: 37523949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the experiences of junior doctors who were shielding during the COVID-19 pandemic: a qualitative study of semi-structured interviews.
    Martin A; Jamieson S
    Lancet; 2023 Nov; 402 Suppl 1():S68. PubMed ID: 37997112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating health and social outcomes of the Big Local community empowerment initiative in England: a mixed method evaluation.
    Popay J; Halliday E; Mead R; Townsend A; Akhter N; Bambra C; Barr B; Anderson de Cuevas R; Daras K; Egan M; Gravenhorst K; Janke K; Kasim AS; McGowan V; Ponsford R; Reynolds J; Whitehead M
    Public Health Res (Southampt); 2023 Oct; 11(9):1-147. PubMed ID: 37929801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How effective were government food box schemes for those who were shielding during the first wave of the COVID-19 pandemic in the United Kingdom? Local and national stakeholder perspectives.
    Lambie-Mumford H; Loopstra R; Gordon K
    Public Health Nutr; 2023 Dec; 26(12):3247-3255. PubMed ID: 37622216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the relationship between working from home, mental and physical health and wellbeing: a systematic review.
    Blank L; Hock E; Cantrell A; Baxter S; Goyder E
    Public Health Res (Southampt); 2023 May; 11(4):1-100. PubMed ID: 37452651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
    Allen D; Gillen E; Rixson L
    JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying models of care to improve outcomes for older people with urgent care needs: a mixed methods approach to develop a system dynamics model.
    Conroy S; Brailsford S; Burton C; England T; Lalseta J; Martin G; Mason S; Maynou-Pujolras L; Phelps K; Preston L; Regen E; Riley P; Street A; van Oppen J
    Health Soc Care Deliv Res; 2023 Sep; 11(14):1-183. PubMed ID: 37830206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mental capacity legislation and communication disability: A cross-sectional survey exploring the impact of the COVID-19 pandemic on the provision of specialist decision-making support by UK SLTs.
    Jayes M; Borrett S; Bose A
    Int J Lang Commun Disord; 2022 Jan; 57(1):172-181. PubMed ID: 34882902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Youth violence intervention programme for vulnerable young people attending emergency departments in London: a rapid evaluation.
    Appleby J; Georghiou T; Ledger J; Rolewicz L; Sherlaw-Johnson C; Tomini SM; Frerich JM; Ng PL
    Health Soc Care Deliv Res; 2023 Jul; 11(10):1-122. PubMed ID: 37470144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Care-home Nurses' responses to the COVID-19 pandemic: Managing ethical conundrums at personal cost: A qualitative study.
    Birt L; Lane K; Corner J; Sanderson K; Bunn D
    J Nurs Scholarsh; 2023 Jan; 55(1):226-238. PubMed ID: 36464814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mental health and life satisfaction among those advised to shield during the COVID-19 pandemic in the UK: a secondary analysis of the Understanding Society longitudinal study.
    Morris SG; Kudrna L; Martin J
    Front Public Health; 2023; 11():1235903. PubMed ID: 37829093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.